NeuroDiscovery AI

Pharma teams use NeuroDiscovery AI to turn raw neurology data into actionable insights: • 5.3M de-identified patient records • 10M imaging studies • AI-driven analytics for outcomes, safety, and market access Transforming years of fragmented data into months of measurable evidence.

Trained on 5.3M+ longitudinal patient journeys and 100M+ clinical notes, NeuroDiscovery AI’s models identify recruitment-ready patients, optimize protocols, and generate regulatory-grade evidence. From Alzheimer’s to rare diseases — precision starts with better data. See how AI is redefining neurology research.

NeuroDiscovery AI connects data, sites, and patients — ending the bottleneck. With AI-powered RWD, sponsors see: ✅ Faster enrollment by 3× ✅ 40% fewer screen failures ✅ $2–6M saved per trial delay avoided Modernize recruitment. Strengthen evidence. Start your transformation today.

80% of trials fail to meet enrollment goals on time. 30% of patients drop out before completion. 50% of sites enroll zero patients. It’s time to modernize with real-world data. NeuroDiscovery AI uses 5.3M neurology records and 80TB of multi-modal data to: • Accelerate patient recruitment • Optimize site selection • Generate real-world evidence faster Turn broken trial operations into data-driven efficiency. Transform your study timeline.

Most neurology trials fail. Recruitment drags on 18 months, costing $600K–$8M daily. Pharma leaders are already fixing this with NeuroDiscovery AI.

Clinical trials are at a breaking point — 80% miss their initial enrollment goals, and half of all sites enroll one or zero patients. NeuroDiscovery AI is fixing this with data, not guesswork. • 5.3M+ neurology patient journeys across 16 states • AI-driven site and patient matching • Predictive RWD analytics to boost enrollment & retention Sponsors are cutting FPI timelines by 4 months and reducing screen failures by 40%. See how we modernize trial operations.